P332: Applying Agile in a Regulated Setting: Balancing Flexibility and Compliance
Poster Presenter
Jason Casavant
Executive Director, Medical Writing
Synterex, Inc. United States
Objectives
To evaluate the applicability of agile, change-driven methodologies in regulated environments by identifying those principles that align with compliance requirements and those that may require adaptation, modification, or a hybrid approach to ensure regulatory adherence.
Method
We examined broad aspects of implementing a flexible approach in regulated settings, focusing on the intersection of iterative development, compliance frameworks, and risk management. Insights were drawn from industry best practices and real-world examples of Agile adoption in project execution.
Results
Principles that Align Well with Regulatory Settings:
-Customer collaboration over contract negotiation: Engaging regulatory agencies and stakeholders early and often promotes continuous feedback.
-Responding to change over following a plan: Regulatory expectations evolve, and an iterative approach can help organizations remain adaptable while maintaining compliance.
-Individuals and interactions over processes and tools: Strong cross-functional collaboration improves compliance outcomes when paired with structured review processes.
Principles That May Require Modification or a Tailored Approach:
-Working software over comprehensive documentation: Rather than prioritize working products, regulated environments mandate extensive documentation. Organizations may need to modify this principle by integrating documentation into iterative cycles rather than eliminating it.
-Frequent delivery of working solutions: Instead of favoring rapid iteration, regulated environments require validation and controlled releases to ensure compliance with Good Clinical Practice (GCP) and other guidelines. Finding an appropriate cadence for iteration without compromising validation may be necessary.
-Simplicity—the art of maximizing the amount of work not done—is essential: Despite the need for efficiency, skipping documentation or compliance steps is not feasible in a regulated setting. Instead, automation and strategic streamlining could be leveraged to maintain efficiency without sacrificing compliance
Conclusion
Agile methodologies hold promise for regulated industries, particularly in clinical research project execution and technology development. While a fully change-driven approach may not always be feasible, organizations could consider a hybrid approach, selective modification of certain principles, or partial adoption to leverage the flexibility of change-driven methodology while ensuring compliance with regulatory requirements. As clinical research continues to evolve, the potential advantages of change-driven methodologies, such as improved stakeholder engagement, adaptability to regulatory changes, and more efficient project execution, suggest it could be more widely utilized in the future.
